What is the Prognosis for KSHV-Associated Cancers?
The prognosis for KSHV-associated cancers varies. For example, the outcome for patients with Kaposi's Sarcoma has improved significantly with the advent of effective antiretroviral therapy for HIV. However, the prognosis for Primary Effusion Lymphoma and Multicentric Castleman's Disease can be poorer, particularly in advanced stages or in patients with severe immune suppression.
